Related Experiment Video
Updated: Jun 7, 2026

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
Published on: December 26, 2016
Minireview: steroid receptor coactivator-3: a multifarious coregulator in mammary gland metastasis
John P Lydon1, Bert W O'Malley
1Department of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030, USA.
Abstract:
A member of the steroid receptor coactivator (SRC)/p160 family, SRC-3 acts as a coregulator for nuclear receptor (NR) and non-NR transcription factors. Such coregulator pleiotropy enables SRC-3 to influence a myriad of signaling networks that are essential for normal physiology and pathophysiology. Although SRC-3's proliferative role in primary tumor formation in the mammary gland is well established, a role for this oncogenic coregulator in tumor cell motility and invasion has only recently been elucidated. In the nucleus, SRC-3 is required for the execution of the epithelial-mesenchymal transition, a programming step which endows an immotile cancer cell with motile and invasive characteristics. Nuclear SRC-3 is also essential for proteolytic breakdown of the extracellular matrix by matrix-metalloproteinases, a process which enables primary tumor cell invasion into the surrounding stroma. At the plasma membrane, however, a truncated isoform of SRC-3 (SRC-3Δ4) serves as a signaling adaptor for the epidermal growth factor→focal adhesion kinase→c-Src signal transduction pathway, a signaling cascade that is central to growth factor-induced cell migration and invasion. Together, these studies underscore a pivotal role for SRC-3 not only as a proto-oncogene but also as a prometastatic factor during the early steps in the invasion-metastasis cascade. Beyond furnishing critical mechanistic insights into SRC-3's involvement in mammary tumor progression, these findings provide opportunities to develop new approaches for breast cancer diagnosis and intervention.
Insights
Steroid receptor coactivator-3 (SRC-3) drives breast cancer invasion and metastasis. This oncogenic coregulator promotes cell motility and extracellular matrix degradation, highlighting its role as a prometastatic factor.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- Steroid receptor coactivator-3 (SRC-3) is a member of the SRC/p160 family, acting as a crucial coregulator in various signaling pathways.
- While SRC-3's role in mammary gland tumor proliferation is known, its function in tumor cell motility and invasion is a recent discovery.
- SRC-3's pleiotropic nature allows it to influence numerous signaling networks vital for both normal physiology and disease states.
Purpose of the Study:
- To elucidate the role of SRC-3 in tumor cell motility and invasion within the context of breast cancer.
- To investigate the mechanisms by which SRC-3 contributes to the early stages of the invasion-metastasis cascade.
- To explore the potential of SRC-3 as a therapeutic target for breast cancer intervention.
Main Methods:
- Analysis of SRC-3's nuclear functions in epithelial-mesenchymal transition (EMT) and extracellular matrix (ECM) degradation.
- Investigation of a truncated SRC-3 isoform (SRC-3Δ4) at the plasma membrane as a signaling adaptor.
- Examination of the epidermal growth factor (EGF) signaling pathway involving focal adhesion kinase (FAK) and c-Src.
Main Results:
- Nuclear SRC-3 is essential for executing EMT, conferring motility and invasive properties to cancer cells.
- SRC-3 facilitates the proteolytic breakdown of the ECM by matrix-metalloproteinases, aiding tumor cell invasion.
- A truncated SRC-3 isoform (SRC-3Δ4) acts as a signaling adaptor in the EGF-induced FAK-c-Src pathway, crucial for cell migration and invasion.
Conclusions:
- SRC-3 functions as both a proto-oncogene and a prometastatic factor in the early invasion-metastasis cascade of breast cancer.
- Understanding SRC-3's multifaceted roles provides critical mechanistic insights into mammary tumor progression.
- These findings offer new avenues for developing diagnostic and therapeutic strategies for breast cancer.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Co-activators and Co-repressors
Co-activators and Co-repressors

